Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applications

Rajendran J.C. Bose, Soo Hong Lee, Hansoo Park

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

Antiproliferative drug (sirolimus or propolis) loaded lipid polymer hybrid nanospheres (LPHNSs) were prepared by single step method. The effects of different lipids on properties of nanocarrier were investigated. Furthermore, anti proliferative efficiency and cytotoxicity of LPHHNSs-propolis or sirolimus were investigated on human aortic smooth muscle cells (HASMCs), and human aortic endothelial primary cells (HAECs) respectively. The characterization of LPHNSs revealed that the lipids used in the formulation influence physiochemical parameters. In vitro studies showed that the encapsulated sirolimus and propolis significantly reduced the proliferation of HASMCs, while maintaining high HAECs viability.

Original languageEnglish
Pages (from-to)284-292
Number of pages9
JournalJournal of Industrial and Engineering Chemistry
Volume36
DOIs
StatePublished - 25 Apr 2016

Keywords

  • Anti proliferation assessment
  • Antiproliferative drugs
  • Cytotoxicity on human aortic endothelial cells
  • Human aortic smooth muscle cells
  • Lipid polymer hybrid nanospheres

Fingerprint

Dive into the research topics of 'Lipid polymer hybrid nanospheres encapsulating antiproliferative agents for stent applications'. Together they form a unique fingerprint.

Cite this